Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Analysts Weigh In On The FDA's Position On E-Cigarettes, Menthols

BTI, C.PM

The Food and Drug Administration is set on introducing restrictions on the sale of electronic cigarettes, including prohibiting most flavored products in convenience stores and gas stations, The Washington Post reported Nov. 8. The Wall Street Journal followed up with its own report Friday that said the FDA could propose a ban on menthol cigarettes.

Height Securities' Stefanie Miller and Wells Fargo's Bonnie Herzog commented on recent media reports in separate research reports.

Height Says Concerns Overblown

The FDA has the authority to regulate tobacco products from the Tobacco Control Act of 2009, Miller said in a note.

The FDA could ban flavors of tobacco products, including menthol, but the Act doesn't allow the FDA to tobacco products immediately, according to Height.

A ban on menthol or other tobacco products is unlikely to occur before 2022, and the tobacco industry would likely slow down the enaction of any ban through litigation, Miller said. 

Nevertheless, last week's reports are "unwelcome news" for cigarette companies like British American Tobacco PLC (NYSE: BTI), Imperial Tobacco Group plc (OTC: IMBBY) and Altria Group Inc (NYSE: MO), according to Height. 

Wells Fargo: Who's At Risk?

Wells Fargo's position on menthol is that science doesn't support a point of view that menthol cigarettes are more harmful than non-menthol, Herzog said in a note.

Given the FDA's position that it will follow a science-based approach, it is unlikely the regulatory body will outright ban menthol — although a proposal to restrict or lower the levels of menthol is reasonable, the analyst said. 

Menthol cigarettes account for around 35 percent of total industry volume in the U.S., Herzog said. British American Tobacco's Reynolds brand is the largest in the menthol segment, as 55 percent of its volume in the U.S. is menthol, she said.

Approximately 21 percent of Altria's volume is menthol and it accounts for around 18 percent of total profit, while about 20 percent of Imperial Tobacco's volume is menthol, the analyst said. 

Price Action

British American Tobacco shares were down nearly 3 percent at $36.95 at the time of publication Tuesday, while Altria was down 1.4 percent at $60.34 and Imperial Tobacco was down 1.89 percent at $33.96. Philip Morris (NYSE: PM) was down about 1.5 percent.

Related Links:

Bernstein Initiates On Tobacco Stocks: Philip Morris 'Leads The Way In The New Nicotine World'

Marlboro Maker Altria May Be In Talks With Cannabis Producer Aphria About A Minority Stake



USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse